Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings

BACKGROUND: Data on the modalities of disclosing genomic secondary findings (SFs) remain scarce. We explore cancer patients’ and the general public’s perspectives about disclosing genomic SFs and the modalities of such disclosure. METHODS: Sixty-one cancer patients (n = 29) and members of the public...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Med Genomics
Hlavní autoři: Cléophat, Jude Emmanuel, Dorval, Michel, El Haffaf, Zaki, Chiquette, Jocelyne, Collins, Stephanie, Malo, Benjamin, Fradet, Vincent, Joly, Yann, Nabi, Hermann
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8236159/
https://ncbi.nlm.nih.gov/pubmed/34174888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-021-01016-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky